The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rapid Infectious Disease Test Market Research Report 2024
Synopsis
A rapid infectious disease test, also known as a rapid diagnostic test (RDT), is a medical test designed to quickly identify the presence or absence of an infectious disease in a patient. These tests provide results within a short period, often within minutes, allowing for immediate diagnosis and timely treatment. Rapid infectious disease tests are particularly useful in situations where fast identification of infections is critical, such as in outbreak investigations, emergency settings, or resource-limited areas where laboratory infrastructure may be limited. They are commonly used for diseases such as influenza, streptococcus (strep throat), HIV, hepatitis, malaria, COVID-19, and many others.
The global Rapid Infectious Disease Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rapid Infectious Disease Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rapid Infectious Disease Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Rapid Infectious Disease Test in Workplace Testing is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Rapid Infectious Disease Test include ELITech Group, Fujirebio, Medical Innovation Ventures, Fago Medical, Bio Group Medical System, Association of Medicine and Analytics, NanoEntek, Shenzhen Medcaptain Medical Technology and Nanjing Liming Bio-products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rapid Infectious Disease Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Infectious Disease Test.
Report Scope
The Rapid Infectious Disease Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rapid Infectious Disease Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapid Infectious Disease Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ELITech Group
Fujirebio
Medical Innovation Ventures
Fago Medical
Bio Group Medical System
Association of Medicine and Analytics
NanoEntek
Shenzhen Medcaptain Medical Technology
Nanjing Liming Bio-products
Tianjin Era Biology Techology
Beijing Baicare Biotechnology
Wuxi BioTeke Corporation
Segment by Type
Influenza Test
Syphilis Test
AIDS Test
Other
Segment by Application
Workplace Testing
Hospital Testing
Other Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rapid Infectious Disease Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A rapid infectious disease test, also known as a rapid diagnostic test (RDT), is a medical test designed to quickly identify the presence or absence of an infectious disease in a patient. These tests provide results within a short period, often within minutes, allowing for immediate diagnosis and timely treatment. Rapid infectious disease tests are particularly useful in situations where fast identification of infections is critical, such as in outbreak investigations, emergency settings, or resource-limited areas where laboratory infrastructure may be limited. They are commonly used for diseases such as influenza, streptococcus (strep throat), HIV, hepatitis, malaria, COVID-19, and many others.
The global Rapid Infectious Disease Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rapid Infectious Disease Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rapid Infectious Disease Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Rapid Infectious Disease Test in Workplace Testing is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Rapid Infectious Disease Test include ELITech Group, Fujirebio, Medical Innovation Ventures, Fago Medical, Bio Group Medical System, Association of Medicine and Analytics, NanoEntek, Shenzhen Medcaptain Medical Technology and Nanjing Liming Bio-products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rapid Infectious Disease Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Infectious Disease Test.
Report Scope
The Rapid Infectious Disease Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rapid Infectious Disease Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapid Infectious Disease Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ELITech Group
Fujirebio
Medical Innovation Ventures
Fago Medical
Bio Group Medical System
Association of Medicine and Analytics
NanoEntek
Shenzhen Medcaptain Medical Technology
Nanjing Liming Bio-products
Tianjin Era Biology Techology
Beijing Baicare Biotechnology
Wuxi BioTeke Corporation
Segment by Type
Influenza Test
Syphilis Test
AIDS Test
Other
Segment by Application
Workplace Testing
Hospital Testing
Other Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rapid Infectious Disease Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rapid Infectious Disease Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Influenza Test
1.2.3 Syphilis Test
1.2.4 AIDS Test
1.2.5 Other
1.3 Market by Application
1.3.1 Global Rapid Infectious Disease Test Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Workplace Testing
1.3.3 Hospital Testing
1.3.4 Other Testing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rapid Infectious Disease Test Market Perspective (2019-2030)
2.2 Rapid Infectious Disease Test Growth Trends by Region
2.2.1 Global Rapid Infectious Disease Test Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rapid Infectious Disease Test Historic Market Size by Region (2019-2024)
2.2.3 Rapid Infectious Disease Test Forecasted Market Size by Region (2025-2030)
2.3 Rapid Infectious Disease Test Market Dynamics
2.3.1 Rapid Infectious Disease Test Industry Trends
2.3.2 Rapid Infectious Disease Test Market Drivers
2.3.3 Rapid Infectious Disease Test Market Challenges
2.3.4 Rapid Infectious Disease Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rapid Infectious Disease Test Players by Revenue
3.1.1 Global Top Rapid Infectious Disease Test Players by Revenue (2019-2024)
3.1.2 Global Rapid Infectious Disease Test Revenue Market Share by Players (2019-2024)
3.2 Global Rapid Infectious Disease Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rapid Infectious Disease Test Revenue
3.4 Global Rapid Infectious Disease Test Market Concentration Ratio
3.4.1 Global Rapid Infectious Disease Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rapid Infectious Disease Test Revenue in 2023
3.5 Rapid Infectious Disease Test Key Players Head office and Area Served
3.6 Key Players Rapid Infectious Disease Test Product Solution and Service
3.7 Date of Enter into Rapid Infectious Disease Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rapid Infectious Disease Test Breakdown Data by Type
4.1 Global Rapid Infectious Disease Test Historic Market Size by Type (2019-2024)
4.2 Global Rapid Infectious Disease Test Forecasted Market Size by Type (2025-2030)
5 Rapid Infectious Disease Test Breakdown Data by Application
5.1 Global Rapid Infectious Disease Test Historic Market Size by Application (2019-2024)
5.2 Global Rapid Infectious Disease Test Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rapid Infectious Disease Test Market Size (2019-2030)
6.2 North America Rapid Infectious Disease Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rapid Infectious Disease Test Market Size by Country (2019-2024)
6.4 North America Rapid Infectious Disease Test Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rapid Infectious Disease Test Market Size (2019-2030)
7.2 Europe Rapid Infectious Disease Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rapid Infectious Disease Test Market Size by Country (2019-2024)
7.4 Europe Rapid Infectious Disease Test Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rapid Infectious Disease Test Market Size (2019-2030)
8.2 Asia-Pacific Rapid Infectious Disease Test Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rapid Infectious Disease Test Market Size by Region (2019-2024)
8.4 Asia-Pacific Rapid Infectious Disease Test Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rapid Infectious Disease Test Market Size (2019-2030)
9.2 Latin America Rapid Infectious Disease Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rapid Infectious Disease Test Market Size by Country (2019-2024)
9.4 Latin America Rapid Infectious Disease Test Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rapid Infectious Disease Test Market Size (2019-2030)
10.2 Middle East & Africa Rapid Infectious Disease Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rapid Infectious Disease Test Market Size by Country (2019-2024)
10.4 Middle East & Africa Rapid Infectious Disease Test Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ELITech Group
11.1.1 ELITech Group Company Detail
11.1.2 ELITech Group Business Overview
11.1.3 ELITech Group Rapid Infectious Disease Test Introduction
11.1.4 ELITech Group Revenue in Rapid Infectious Disease Test Business (2019-2024)
11.1.5 ELITech Group Recent Development
11.2 Fujirebio
11.2.1 Fujirebio Company Detail
11.2.2 Fujirebio Business Overview
11.2.3 Fujirebio Rapid Infectious Disease Test Introduction
11.2.4 Fujirebio Revenue in Rapid Infectious Disease Test Business (2019-2024)
11.2.5 Fujirebio Recent Development
11.3 Medical Innovation Ventures
11.3.1 Medical Innovation Ventures Company Detail
11.3.2 Medical Innovation Ventures Business Overview
11.3.3 Medical Innovation Ventures Rapid Infectious Disease Test Introduction
11.3.4 Medical Innovation Ventures Revenue in Rapid Infectious Disease Test Business (2019-2024)
11.3.5 Medical Innovation Ventures Recent Development
11.4 Fago Medical
11.4.1 Fago Medical Company Detail
11.4.2 Fago Medical Business Overview
11.4.3 Fago Medical Rapid Infectious Disease Test Introduction
11.4.4 Fago Medical Revenue in Rapid Infectious Disease Test Business (2019-2024)
11.4.5 Fago Medical Recent Development
11.5 Bio Group Medical System
11.5.1 Bio Group Medical System Company Detail
11.5.2 Bio Group Medical System Business Overview
11.5.3 Bio Group Medical System Rapid Infectious Disease Test Introduction
11.5.4 Bio Group Medical System Revenue in Rapid Infectious Disease Test Business (2019-2024)
11.5.5 Bio Group Medical System Recent Development
11.6 Association of Medicine and Analytics
11.6.1 Association of Medicine and Analytics Company Detail
11.6.2 Association of Medicine and Analytics Business Overview
11.6.3 Association of Medicine and Analytics Rapid Infectious Disease Test Introduction
11.6.4 Association of Medicine and Analytics Revenue in Rapid Infectious Disease Test Business (2019-2024)
11.6.5 Association of Medicine and Analytics Recent Development
11.7 NanoEntek
11.7.1 NanoEntek Company Detail
11.7.2 NanoEntek Business Overview
11.7.3 NanoEntek Rapid Infectious Disease Test Introduction
11.7.4 NanoEntek Revenue in Rapid Infectious Disease Test Business (2019-2024)
11.7.5 NanoEntek Recent Development
11.8 Shenzhen Medcaptain Medical Technology
11.8.1 Shenzhen Medcaptain Medical Technology Company Detail
11.8.2 Shenzhen Medcaptain Medical Technology Business Overview
11.8.3 Shenzhen Medcaptain Medical Technology Rapid Infectious Disease Test Introduction
11.8.4 Shenzhen Medcaptain Medical Technology Revenue in Rapid Infectious Disease Test Business (2019-2024)
11.8.5 Shenzhen Medcaptain Medical Technology Recent Development
11.9 Nanjing Liming Bio-products
11.9.1 Nanjing Liming Bio-products Company Detail
11.9.2 Nanjing Liming Bio-products Business Overview
11.9.3 Nanjing Liming Bio-products Rapid Infectious Disease Test Introduction
11.9.4 Nanjing Liming Bio-products Revenue in Rapid Infectious Disease Test Business (2019-2024)
11.9.5 Nanjing Liming Bio-products Recent Development
11.10 Tianjin Era Biology Techology
11.10.1 Tianjin Era Biology Techology Company Detail
11.10.2 Tianjin Era Biology Techology Business Overview
11.10.3 Tianjin Era Biology Techology Rapid Infectious Disease Test Introduction
11.10.4 Tianjin Era Biology Techology Revenue in Rapid Infectious Disease Test Business (2019-2024)
11.10.5 Tianjin Era Biology Techology Recent Development
11.11 Beijing Baicare Biotechnology
11.11.1 Beijing Baicare Biotechnology Company Detail
11.11.2 Beijing Baicare Biotechnology Business Overview
11.11.3 Beijing Baicare Biotechnology Rapid Infectious Disease Test Introduction
11.11.4 Beijing Baicare Biotechnology Revenue in Rapid Infectious Disease Test Business (2019-2024)
11.11.5 Beijing Baicare Biotechnology Recent Development
11.12 Wuxi BioTeke Corporation
11.12.1 Wuxi BioTeke Corporation Company Detail
11.12.2 Wuxi BioTeke Corporation Business Overview
11.12.3 Wuxi BioTeke Corporation Rapid Infectious Disease Test Introduction
11.12.4 Wuxi BioTeke Corporation Revenue in Rapid Infectious Disease Test Business (2019-2024)
11.12.5 Wuxi BioTeke Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Rapid Infectious Disease Test Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Influenza Test
Table 3. Key Players of Syphilis Test
Table 4. Key Players of AIDS Test
Table 5. Key Players of Other
Table 6. Global Rapid Infectious Disease Test Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Rapid Infectious Disease Test Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Rapid Infectious Disease Test Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Rapid Infectious Disease Test Market Share by Region (2019-2024)
Table 10. Global Rapid Infectious Disease Test Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Rapid Infectious Disease Test Market Share by Region (2025-2030)
Table 12. Rapid Infectious Disease Test Market Trends
Table 13. Rapid Infectious Disease Test Market Drivers
Table 14. Rapid Infectious Disease Test Market Challenges
Table 15. Rapid Infectious Disease Test Market Restraints
Table 16. Global Rapid Infectious Disease Test Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Rapid Infectious Disease Test Market Share by Players (2019-2024)
Table 18. Global Top Rapid Infectious Disease Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Infectious Disease Test as of 2023)
Table 19. Ranking of Global Top Rapid Infectious Disease Test Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Rapid Infectious Disease Test Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Rapid Infectious Disease Test Product Solution and Service
Table 23. Date of Enter into Rapid Infectious Disease Test Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Rapid Infectious Disease Test Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Rapid Infectious Disease Test Revenue Market Share by Type (2019-2024)
Table 27. Global Rapid Infectious Disease Test Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Rapid Infectious Disease Test Revenue Market Share by Type (2025-2030)
Table 29. Global Rapid Infectious Disease Test Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Rapid Infectious Disease Test Revenue Market Share by Application (2019-2024)
Table 31. Global Rapid Infectious Disease Test Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Rapid Infectious Disease Test Revenue Market Share by Application (2025-2030)
Table 33. North America Rapid Infectious Disease Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Rapid Infectious Disease Test Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Rapid Infectious Disease Test Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Rapid Infectious Disease Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Rapid Infectious Disease Test Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Rapid Infectious Disease Test Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Rapid Infectious Disease Test Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Rapid Infectious Disease Test Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Rapid Infectious Disease Test Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Rapid Infectious Disease Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Rapid Infectious Disease Test Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rapid Infectious Disease Test Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Rapid Infectious Disease Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Rapid Infectious Disease Test Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Rapid Infectious Disease Test Market Size by Country (2025-2030) & (US$ Million)
Table 48. ELITech Group Company Detail
Table 49. ELITech Group Business Overview
Table 50. ELITech Group Rapid Infectious Disease Test Product
Table 51. ELITech Group Revenue in Rapid Infectious Disease Test Business (2019-2024) & (US$ Million)
Table 52. ELITech Group Recent Development
Table 53. Fujirebio Company Detail
Table 54. Fujirebio Business Overview
Table 55. Fujirebio Rapid Infectious Disease Test Product
Table 56. Fujirebio Revenue in Rapid Infectious Disease Test Business (2019-2024) & (US$ Million)
Table 57. Fujirebio Recent Development
Table 58. Medical Innovation Ventures Company Detail
Table 59. Medical Innovation Ventures Business Overview
Table 60. Medical Innovation Ventures Rapid Infectious Disease Test Product
Table 61. Medical Innovation Ventures Revenue in Rapid Infectious Disease Test Business (2019-2024) & (US$ Million)
Table 62. Medical Innovation Ventures Recent Development
Table 63. Fago Medical Company Detail
Table 64. Fago Medical Business Overview
Table 65. Fago Medical Rapid Infectious Disease Test Product
Table 66. Fago Medical Revenue in Rapid Infectious Disease Test Business (2019-2024) & (US$ Million)
Table 67. Fago Medical Recent Development
Table 68. Bio Group Medical System Company Detail
Table 69. Bio Group Medical System Business Overview
Table 70. Bio Group Medical System Rapid Infectious Disease Test Product
Table 71. Bio Group Medical System Revenue in Rapid Infectious Disease Test Business (2019-2024) & (US$ Million)
Table 72. Bio Group Medical System Recent Development
Table 73. Association of Medicine and Analytics Company Detail
Table 74. Association of Medicine and Analytics Business Overview
Table 75. Association of Medicine and Analytics Rapid Infectious Disease Test Product
Table 76. Association of Medicine and Analytics Revenue in Rapid Infectious Disease Test Business (2019-2024) & (US$ Million)
Table 77. Association of Medicine and Analytics Recent Development
Table 78. NanoEntek Company Detail
Table 79. NanoEntek Business Overview
Table 80. NanoEntek Rapid Infectious Disease Test Product
Table 81. NanoEntek Revenue in Rapid Infectious Disease Test Business (2019-2024) & (US$ Million)
Table 82. NanoEntek Recent Development
Table 83. Shenzhen Medcaptain Medical Technology Company Detail
Table 84. Shenzhen Medcaptain Medical Technology Business Overview
Table 85. Shenzhen Medcaptain Medical Technology Rapid Infectious Disease Test Product
Table 86. Shenzhen Medcaptain Medical Technology Revenue in Rapid Infectious Disease Test Business (2019-2024) & (US$ Million)
Table 87. Shenzhen Medcaptain Medical Technology Recent Development
Table 88. Nanjing Liming Bio-products Company Detail
Table 89. Nanjing Liming Bio-products Business Overview
Table 90. Nanjing Liming Bio-products Rapid Infectious Disease Test Product
Table 91. Nanjing Liming Bio-products Revenue in Rapid Infectious Disease Test Business (2019-2024) & (US$ Million)
Table 92. Nanjing Liming Bio-products Recent Development
Table 93. Tianjin Era Biology Techology Company Detail
Table 94. Tianjin Era Biology Techology Business Overview
Table 95. Tianjin Era Biology Techology Rapid Infectious Disease Test Product
Table 96. Tianjin Era Biology Techology Revenue in Rapid Infectious Disease Test Business (2019-2024) & (US$ Million)
Table 97. Tianjin Era Biology Techology Recent Development
Table 98. Beijing Baicare Biotechnology Company Detail
Table 99. Beijing Baicare Biotechnology Business Overview
Table 100. Beijing Baicare Biotechnology Rapid Infectious Disease Test Product
Table 101. Beijing Baicare Biotechnology Revenue in Rapid Infectious Disease Test Business (2019-2024) & (US$ Million)
Table 102. Beijing Baicare Biotechnology Recent Development
Table 103. Wuxi BioTeke Corporation Company Detail
Table 104. Wuxi BioTeke Corporation Business Overview
Table 105. Wuxi BioTeke Corporation Rapid Infectious Disease Test Product
Table 106. Wuxi BioTeke Corporation Revenue in Rapid Infectious Disease Test Business (2019-2024) & (US$ Million)
Table 107. Wuxi BioTeke Corporation Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rapid Infectious Disease Test Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Rapid Infectious Disease Test Market Share by Type: 2023 VS 2030
Figure 3. Influenza Test Features
Figure 4. Syphilis Test Features
Figure 5. AIDS Test Features
Figure 6. Other Features
Figure 7. Global Rapid Infectious Disease Test Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Rapid Infectious Disease Test Market Share by Application: 2023 VS 2030
Figure 9. Workplace Testing Case Studies
Figure 10. Hospital Testing Case Studies
Figure 11. Other Testing Case Studies
Figure 12. Rapid Infectious Disease Test Report Years Considered
Figure 13. Global Rapid Infectious Disease Test Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Rapid Infectious Disease Test Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Rapid Infectious Disease Test Market Share by Region: 2023 VS 2030
Figure 16. Global Rapid Infectious Disease Test Market Share by Players in 2023
Figure 17. Global Top Rapid Infectious Disease Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Infectious Disease Test as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Rapid Infectious Disease Test Revenue in 2023
Figure 19. North America Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Rapid Infectious Disease Test Market Share by Country (2019-2030)
Figure 21. United States Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Rapid Infectious Disease Test Market Share by Country (2019-2030)
Figure 25. Germany Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Rapid Infectious Disease Test Market Share by Region (2019-2030)
Figure 33. China Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Rapid Infectious Disease Test Market Share by Country (2019-2030)
Figure 41. Mexico Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Rapid Infectious Disease Test Market Share by Country (2019-2030)
Figure 45. Turkey Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Rapid Infectious Disease Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. ELITech Group Revenue Growth Rate in Rapid Infectious Disease Test Business (2019-2024)
Figure 48. Fujirebio Revenue Growth Rate in Rapid Infectious Disease Test Business (2019-2024)
Figure 49. Medical Innovation Ventures Revenue Growth Rate in Rapid Infectious Disease Test Business (2019-2024)
Figure 50. Fago Medical Revenue Growth Rate in Rapid Infectious Disease Test Business (2019-2024)
Figure 51. Bio Group Medical System Revenue Growth Rate in Rapid Infectious Disease Test Business (2019-2024)
Figure 52. Association of Medicine and Analytics Revenue Growth Rate in Rapid Infectious Disease Test Business (2019-2024)
Figure 53. NanoEntek Revenue Growth Rate in Rapid Infectious Disease Test Business (2019-2024)
Figure 54. Shenzhen Medcaptain Medical Technology Revenue Growth Rate in Rapid Infectious Disease Test Business (2019-2024)
Figure 55. Nanjing Liming Bio-products Revenue Growth Rate in Rapid Infectious Disease Test Business (2019-2024)
Figure 56. Tianjin Era Biology Techology Revenue Growth Rate in Rapid Infectious Disease Test Business (2019-2024)
Figure 57. Beijing Baicare Biotechnology Revenue Growth Rate in Rapid Infectious Disease Test Business (2019-2024)
Figure 58. Wuxi BioTeke Corporation Revenue Growth Rate in Rapid Infectious Disease Test Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
